newsfilter
← Latest News
GlobeNewswire·

Maze Therapeutics Appoints Misbah Tahir as Chief Financial Officer

SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (NASDAQ:MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with kidney